Treatment with the antibody against ITGA6 and P5G10 de-adhered acute lymphoblastic leukemia cells from the stroma and reduced stromal support in the face of chemotherapeutic damage [145]. Here, ITGA6 is linked to acute lymphoblastic leukemia.